199 related articles for article (PubMed ID: 11603386)
21. Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis.
Sato S; Nagaoka T; Hasegawa M; Nishijima C; Takehara K
Dermatology; 2000; 200(3):196-201. PubMed ID: 10828626
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis.
Takahashi H; Kuroki Y; Tanaka H; Saito T; Kurokawa K; Chiba H; Sagawa A; Nagae H; Abe S
Am J Respir Crit Care Med; 2000 Jul; 162(1):258-63. PubMed ID: 10903251
[TBL] [Abstract][Full Text] [Related]
23. Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis.
Yanaba K; Yoshizaki A; Asano Y; Kadono T; Sato S
J Rheumatol; 2011 Oct; 38(10):2193-7. PubMed ID: 21807780
[TBL] [Abstract][Full Text] [Related]
24. Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis.
Hasegawa M; Fujimoto M; Hamaguchi Y; Matsushita T; Inoue K; Sato S; Takehara K
J Rheumatol; 2011 May; 38(5):877-84. PubMed ID: 21239758
[TBL] [Abstract][Full Text] [Related]
25. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
26. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
[TBL] [Abstract][Full Text] [Related]
27. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
[TBL] [Abstract][Full Text] [Related]
28. [Early diagnosis of rheumatoid polyarthritis].
Fallet GH
Schweiz Med Wochenschr; 1970 Dec; 100(49):2110-6 concl. PubMed ID: 4099822
[No Abstract] [Full Text] [Related]
29. Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease.
Ihn H; Asano Y; Kubo M; Yamane K; Jinnin M; Yazawa N; Fujimoto M; Tamaki K
Rheumatology (Oxford); 2002 Nov; 41(11):1268-72. PubMed ID: 12421999
[TBL] [Abstract][Full Text] [Related]
30. Decreased serum ACE2 levels in patients with connective tissue diseases.
Tang X; Geng L; Feng X; Sun L
Rheumatology (Oxford); 2021 Sep; 60(9):4401-4406. PubMed ID: 33369650
[TBL] [Abstract][Full Text] [Related]
31. [Undifferentiated connective tissue disease].
Bodolay E; Szegedi G
Orv Hetil; 2009 May; 150(19):867-72. PubMed ID: 19403430
[TBL] [Abstract][Full Text] [Related]
32. A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies.
Gkoutzourelas A; Liaskos C; Simopoulou T; Katsiari C; Efthymiou G; Scheper T; Meyer W; Tsirogianni A; Tsigalou C; Dardiotis E; Daoussis D; Sakkas LI; Bogdanos DP
Rheumatol Int; 2020 Oct; 40(10):1689-1699. PubMed ID: 32681396
[TBL] [Abstract][Full Text] [Related]
33. CCL13 is a promising diagnostic marker for systemic sclerosis.
Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
Br J Dermatol; 2010 Feb; 162(2):332-6. PubMed ID: 19747218
[TBL] [Abstract][Full Text] [Related]
34. Anti-cyclic citrullinated peptide antibody in systemic sclerosis.
Morita Y; Muro Y; Sugiura K; Tomita Y
Clin Exp Rheumatol; 2008; 26(4):542-7. PubMed ID: 18799082
[TBL] [Abstract][Full Text] [Related]
35. Previous diagnosis of Sjögren's Syndrome as rheumatoid arthritis or systemic lupus erythematosus.
Rasmussen A; Radfar L; Lewis D; Grundahl K; Stone DU; Kaufman CE; Rhodus NL; Segal B; Wallace DJ; Weisman MH; Venuturupalli S; Kurien BT; Lessard CJ; Sivils KL; Scofield RH
Rheumatology (Oxford); 2016 Jul; 55(7):1195-201. PubMed ID: 26998859
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
[TBL] [Abstract][Full Text] [Related]
37. Large macrophage colony-forming cells identical to high proliferative potential colony-forming cells in peripheral blood of patients with collagen vascular diseases: high occurrence among patients with systemic sclerosis and dermatomyositis.
Horie S; Minota S; Kano S
J Rheumatol; 2000 Oct; 27(10):2378-81. PubMed ID: 11036833
[TBL] [Abstract][Full Text] [Related]
38. Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases.
Sfikakis PP; Charalambopoulos D; Vaiopoulos G; Mavrikakis M
Clin Rheumatol; 1999; 18(1):28-32. PubMed ID: 10088945
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
40. [Significance of glucose-6-phosphate isomerase assay in early diagnosis of rheumatoid arthritis].
Xu J; Liu J; Zhu L; Zhang XW; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):942-946. PubMed ID: 27987494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
